Golfer247 - The latest news and products from the world of golf
Main Menu | News By Date | News By Supplier | News By Category | About Us
 

LEADING SCIENTISTS JOIN BTG NETWORK TO EXPLORE POTENTIAL OF NANOTECHNOLOGY
09 October 2006 - BTG

BTG, the global technology commercialisation company, today launched the BTG Nanotechnology Network, a think-tank of leading international scientists working in the fields of nanotechnology.

BTG, the global technology commercialisation company, today launched the BTG Nanotechnology Network, a think-tank of leading international scientists working in the fields of nanotechnology.

Biologists, chemists and physicists from the Universities of Leeds, Oxford, Coventry, Portsmouth, Leicester, Edinburgh and Delft in the Netherlands, the Marie Curie Research Institute and the National Physics Laboratory are meeting today to share their research and findings on developments in nanotechnology within their field of expertise.

Topics to be addressed cover the interface between nanobiology and electronics and include papers on topics such as: applications in nanotechnology, chemistry and medicine; detection of single molecules using fluorescence; and protein DNA interactions at a single molecular level.

Ian Harvey, BTG’s Chief Executive Officer said: "Nanotechnology has the potential to shape the future of almost every scientific discipline. These disciplines usually work in isolation, so bringing together these leaders in their fields allows them to join forces to push the boundaries of nanotechnology. The possibilities are endless and very exciting."

Dr. Keith Firman, Principal Lecturer in Molecular Biology, University of Portsmouth said: "Nanotechnology is a major development in the advance of science. As with all emerging fields, the potential for commercially viable technologies is huge, whether it’s a new way of delivering medicines in the body or a way of improving communications. By backing this network, BTG can help us find, develop and commercialise exciting technologies in this arena."

Nanotechnology – technology based on the visualisation and manipulation of individual molecules - is currently being developed in the disciplines of biology, molecular science, chemistry, bio-medics and physics.

http://www.btgplc.com

About: BTG
BTG is an intellectual property and technology commercialisation company that operates internationally. BTG creates value by investing in intellectual property and technology development, and in early stage ventures. We realise value through technology licensing, patent assertion and sale of equity investments. Through a multidisciplinary approach, we apply intellectual property and commercial expertise, together with specialist skills in science and technology, to create major product opportunities in the health and high tech sectors. BTG has commercialised important innovations, including Magnetic Resonance Imaging, Multilevel Cell Memory, Campath (alemtuzumab), the first monoclonal antibody treatment for chronic lymphocytic leukaemia, and recombinant Factor IX blood clotting protein. BTG operates through wholly owned subsidiaries BTG International Ltd and BTG International Inc in the UK and USA, respectively.


More News:
  • For October 2006
  • From BTG
  • For Polymer OLED Devices

 

©2008 New Materials International